Evidence map›Paper›PMID 26791532›Full record

ArticleHistochemistry and cell biology2016

Tissue-of-origin-specific gene repositioning in breast and prostate cancer.

Karen J Meaburn, Olufunmilayo Agunloye, Michelle Devine, Marc Leshner, Gregory W Roloff, Lawrence D True, Tom Misteli

Open access · greenAbstract read
In one paragraph

Article in Histochemistry and cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. The emerging landscape ofF1000Research · 2017
    Review
  15. Article
  16. In focus in Vienna: the cell nucleus.Histochemistry and cell biology · 2016
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Karen J MeaburnNational Cancer Institute, NIH, Bethesda, MD, 20892, USA. meaburnk@mail.nih.gov.
Olufunmilayo AgunloyeNational Cancer Institute, NIH, Bethesda, MD, 20892, USA.
Michelle DevineNational Cancer Institute, NIH, Bethesda, MD, 20892, USA.
Marc LeshnerNational Cancer Institute, NIH, Bethesda, MD, 20892, USA.
Gregory W RoloffNational Cancer Institute, NIH, Bethesda, MD, 20892, USA.
Lawrence D TrueDepartment of Pathology, University of Washington, Seattle, WA, 98195, USA.
Tom MisteliNational Cancer Institute, NIH, Bethesda, MD, 20892, USA. mistelit@mail.nih.gov.
National Cancer Institute · USUniversity of Washington · US

Funding

TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI John Kyung Lee · 2002 to 2026
$58.1M
Nuclear Architecture and DiseaseZIABC010309 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MISTELI, THOMAS A · 2009 to 2025
$39.8M
Intramural NIH HHS Z99 CA999999Intramural NIH HHS ZIA BC010309NCI NIH HHS P50 CA097186NCI NIH HHS P50CA097186
6 · The paper itself

Abstract

Genes have preferential non-random spatial positions within the cell nucleus. The nuclear position of a subset of genes differ between cell types and some genes undergo repositioning events in disease, including cancer. It is currently unclear whether the propensity of a gene to reposition reflects an intrinsic property of the locus or the tissue. Using quantitative FISH analysis of a set of genes which reposition in cancer, we test here the tissue specificity of gene repositioning in normal and malignant breast or prostate tissues. We find tissue-specific organization of the genome in normal breast and prostate with 40 % of genes occupying differential positions between the two tissue types. While we demonstrate limited overlap between gene sets that repositioned in breast and prostate cancer, we identify two genes that undergo disease-related gene repositioning in both cancer types. Our findings indicate that gene repositioning in cancer is tissue-of-origin specific.

Indexed as

Breast NeoplasmsFemaleHumansIn Situ Hybridization, FluorescenceMaleOrgan SpecificityProstatic NeoplasmsBreast cancerNuclear architectureProstate cancerSpatial gene positioningTissue specificity

Identifiers

PMID26791532
PMCPMC4795970
OpenAlexW2282923723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.